IL33 and rheumatoid arthritis: On the contrary, RA patients bearing the IL-33 rs16924159 GG genotype had lower values of DAS28 at week 24 of anti-TNF treatment than patients carrying the other genotypes (p = 0.049, pc = NS, OR = 1.97, CI95% = 1.00–3.93).